Questão de Língua Inglesa

09 It is thought at least 1.6 million people in the UK have tried weight-loss drugs in the past 10 year, and that number is expected to rise. Most are being bought privately through online 11 pharmacies. 12 The percentage of body weight lost when taking weight-loss medication can vary widely. 13 In this study, based on the experiences of 15,000 people taking weight-loss medications, they 14 lost an average of 11.7% of their body weight during roughly eight months of treatment. Some 15 lost 30% of their weight, while others lost little or nothing. 16 All of those 15,000 had previously signed up for gene-testing by the company 23andMe, 17 which used that data to chart the experiences of people taking weight-loss drugs. By analysing 18 millions of their genetic variants, the researchers found a pattern suggesting a link between 19 some variants and the effectiveness of the drugs. 20 Professor Ruth Loos, from the University of Copenhagen, who wrote about the research in 21 Nature journal, said: “The study found a genetic variant associated with weight loss, which was 22 also associated with nausea”. 23 “People lose more weight if they have this variant.” And that extra lost weight amounted to 24 about 0.76 kg (1.6 lbs) on average—but those people who carry two copies of the genes can 25 double the amount they lose. 26 The variant is high in people with European ancestry—64% carry one copy, while 16% of 27 people carry two copies, she says. That compares to 7% of African Americans who carry a copy 28 of the gene. “If you carry the variant, you will lose more weight,” says Prof Loos. 29 The study found another variant that could be responsible for people experiencing 30 side-effects such as nausea and vomiting when taking tirzepatide. And that could mean up to 31 1% of people taking the drug will have really bad vomiting—nearly 15 times worse than normal. 32 Prof Loos said the genetic effect, while modest, “is similar to other factors—and not trivial”. 33 However, she said the findings need to be reproduced in other studies and, to date, that has not 34 happened. 35 For Dr Marie Spreckley, from the University of Cambridge, “genetics is only one part of a 36 much more complex picture”. In the long term, taking genetic and other information together 37 could help guide the choice of which weight-loss drug to use, based on the potential 38 benefits—something called “precision medicine”. 39 But we are not there yet, said Professor Naveed Sattar, metabolic health expert from the 40 University of Glasgow. “Overall, these findings are scientifically interesting, but they are a long 41 way from changing clinical practice,” he said. “What we really need now is more robust trial data 42 to better define the balance of benefits and harms with these and many other emerging newer 43 therapies”. (Available at: https://www.bbc.com/news/articles/cn5317dkqnxo – text specially adapted for this test).